Get the Stockscreener App
0.223
9.20%
-0.0226
After Hours:
.22
-0.003
-1.35%
Scorpius Holdings Inc stock is traded at $0.223, with a volume of 693.69K.
It is down -9.20% in the last 24 hours and down -48.39% over the past month.
See More
Previous Close:
$0.2456
Open:
$0.275
24h Volume:
693.69K
Relative Volume:
0.34
Market Cap:
$1.24M
Revenue:
$7.84M
Net Income/Loss:
$-55.03M
P/E Ratio:
-0.1052
EPS:
-2.12
Net Cash Flow:
$-41.00M
1W Performance:
-15.85%
1M Performance:
-48.39%
6M Performance:
-79.54%
1Y Performance:
+0.00%
1-Day Range:
$0.2075
$0.275
1-Week Range:
$0.2041
$0.275
52-Week Range:
$0.2041
$7.2192
Scorpius Holdings Inc Stock (SCPX) Company Profile
Compare SCPX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SCPX
Scorpius Holdings Inc
|
0.223 | 1.24M | 7.84M | -55.03M | -41.00M | -2.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.32 | 122.13B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 78.30B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.73B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.47B | 3.30B | -501.07M | 1.03B | -2.1146 |
Scorpius Holdings Inc Stock (SCPX) Latest News
Healthy Upside Potential: Scorpius Holdings Inc (SCPX) - SETE News
Company’s Banking Stock: Dissecting a -67.36% Quarterly Revenue Decline Amid Growth - The InvestChronicle
A stock that deserves closer examination: Scorpius Holdings Inc (SCPX) - US Post News
Closing Figures Unveiled: Scorpius Holdings Inc (SCPX) Drop -7.47, Closes at 0.25 - The Dwinnex
Market Momentum Report: Lyell Immunopharma Inc (LYEL)’s Negative Close at 0.58 - The Dwinnex
Scorpius Holdings secures $600,000 through promissory note - MSN
Scorpius Holdings secures $600,000 through promissory note By Investing.com - Investing.com South Africa
Heat Biologics, Inc. Announces the Promotion of William Ostrander to Chief Financial Officer - Marketscreener.com
Heat Biologics, Inc. Announces Promotions of Taylor Schreiber to Chief Scientific Officer and Melissa Price to Vice President of Product Development - Marketscreener.com
Scorpius Holdings, Inc. Launches Scorpius Ventures -November 19, 2024 at 07:30 am EST - Marketscreener.com
Scorpius Holdings, Inc. announced that it has received $0.225 million in funding -November 26, 2024 - Marketscreener.com
Scorpius Holdings, Inc. announced that it expects to receive $12.05 million in funding -December 04, 2024 - Marketscreener.com
Scorpius Holdings Set to Launch First Mammalian Cgmp Campaign At San Antonio Facility in the 2024 3Rd Quarter - Marketscreener.com
Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™ - GlobeNewswire
Scorpius Partners with KaloCyte on Revolutionary Artificial Blood Cell Manufacturing - StockTitan
Scorpius announces 1-for-20 reverse stock split - MSN
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Scorpius Holdings Cancels Planned Reverse Stock Split - GlobeNewswire
Scorpius Holdings Cancels Planned 1-for-20 Reverse Stock Split in Surprise Move - StockTitan
Nasdaq Surges Over 300 Points; State Street Earnings Top Views - Benzinga
Dow Jumps Over 300 Points; US Industrial Production Beats Estimates - Benzinga
Scorpius Holdings Implements Reverse Stock Split Strategy - TipRanks
Scorpius Holdings Announces Reverse Stock Split - The Manila Times
Scorpius Holdings Announces 1-for-20 Reverse Stock Split to Maintain NYSE American Listing - StockTitan
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Scorpius Holdings faces funding challenges, seeks capital By Investing.com - Investing.com Canada
Scorpius Holdings faces funding challenges, seeks capital - Investing.com
Scorpius Holdings Readies Public Offering Amid Going-Concern Warning - MarketWatch
Form PRE 14A Scorpius Holdings, Inc. For: Jan 16 - StreetInsider.com
Scorpius Holdings, Inc. announced that it expects to receive $12.05 million in funding - Marketscreener.com
Scorpius Holdings, Inc. announced that it has received $0.225 million in funding - Marketscreener.com
Scorpius Holdings, Inc. Launches Scorpius Ventures - Marketscreener.com
Nvidia earnings more important than CPI, Fed: Barclays - Investing.com
Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring Model - The Manila Times
Scorpius Holdings Introduces Scorpius Ventures - Contract Pharma
Scorpius Holdings Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability - The Manila Times
Scorpius Holdings Inc (SCPX) Quarterly 10-Q Report - Quartzy
Scorpius Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Scorpius Holdings Reports 142% Revenue Growth, Despite $10.1M Q3 Loss | SCPX Stock News - StockTitan
Scorpius Holdings Reports Third Quarter 2024 Results, - GlobeNewswire
Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership Agreement - StockTitan
Scorpius Holdings Announces Implementation of New Cost Savings Measures Expected to Save Over $2 Million Annually - The Manila Times
Scorpius Partners with Biotech Firm to Boost U.S. Biomanufacturing Capabilities - Yahoo Finance
Scorpius Holdings Announces Partnership with U.S. Biotech Company - The Manila Times
Public company puts headquarters up for sublease amid pivot to Texas - Triangle Business Journal
Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats - The Manila Times
Scorpius Holdings Selected to Join Medical CBRN Defense - GlobeNewswire
SCPXScorpius Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing Opportunities - The Manila Times
Chesterfield accountancy practice acquired by Xeinadin - East Midlands Business Link
Truist Maintains Buy Rating on Crowdstrike with $325 Target - AskTraders
Scorpius Holdings Inc Stock (SCPX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.09%
Cap:
|
Volume (24h):